Publicação
Impact of corporate social responsibility in the European pharmaceutical market
| dc.contributor.advisor | Marques, Ana | |
| dc.contributor.author | Martins, Ana Carolina Amaral | |
| dc.date.accessioned | 2015-08-26T11:07:58Z | |
| dc.date.available | 2015-08-26T11:07:58Z | |
| dc.date.issued | 2015-01 | |
| dc.description | A Work Project, presented as part of the requirements for the Award of a Masters Degree in Finance from the Nova School of Business and Economics | en |
| dc.description.abstract | The objective of this master thesis is to evaluate the impact of CSR measures in the financial performance of the European pharmaceutical industry. By definition, CSR measures is quantified as corporate social disclosure considering the published CSR keywords on the annual reports of the selected companies, over four fiscal years (2010-2013). The financial performance of the companies were measured as return on assets (ROA) and Tobin’s Q. In order to defend the hypothesis developed, a multivariate regression is performed. The results obtained show no significant impact on the financial performance of a company nor in the short-time, nor in the long-time. Moreover, by comparison with other studies, it was possible to conclude that the financial performance is differently affected when considering different industries. | por |
| dc.description.sponsorship | UNL - NSBE | por |
| dc.identifier.tid | 201474980 | |
| dc.identifier.uri | http://hdl.handle.net/10362/15383 | |
| dc.language.iso | por | por |
| dc.title | Impact of corporate social responsibility in the European pharmaceutical market | por |
| dc.type | master thesis | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess | por |
| rcaap.type | masterThesis | por |
| thesis.degree.discipline | Finance | por |
| thesis.degree.level | Masters | por |
| thesis.degree.name | A Work Project, presented as part of the requirements for the Award of a Masters Degree in Finance from the NOVA – School of Business and Economics | por |